Preparing for China · patient guide

Imaging needed for a liver cancer review

For a liver cancer review, the imaging that matters is the set that shows the liver lesions, the liver's background condition and whether cancer has spread. Most patients already hold CT, MRI or ultrasound studies; the practical task is to send the original image files and reports, not only a summary letter. The treating team decides whether new imaging is needed in China.

Go to the practical guidance ↓
AI illustration: A desk with a blue binder, a stack of CDs, a spiral notebook with a pen, and a potted plant near a window.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a liver cancer review actually needs from imaging

A liver cancer review is a clinical assessment, and imaging is one input among several. The reviewing team needs to see where the tumour or tumours sit in the liver, how large they are, how many there are, and how they relate to the liver's blood vessels and bile ducts. That information shapes whether surgery, ablation, embolisation, systemic therapy or another route is discussed.

Imaging also helps the team understand the liver behind the cancer. Many liver cancers arise in a liver already affected by cirrhosis, chronic hepatitis or other long-standing disease. Scans that describe liver texture, spleen size, fluid or enlarged veins give the clinician context that a tumour measurement alone cannot.

Staging is the third job. The team needs to know whether disease appears confined to the liver or has reached lymph nodes, lungs, bone or elsewhere. That is why a review often draws on more than one study rather than a single picture of the liver.

None of this means a patient should arrive with a perfect file. It means the useful starting point is the imaging that already exists, sent in a form a radiologist and clinician can actually read.

Which studies patients usually already have

Patients investigated for liver cancer commonly hold a mix of studies. A multiphase CT or MRI of the liver is often the central study, because it captures how lesions behave as contrast passes through the liver's blood supply. Ultrasound may be the earliest study that flagged an abnormality. A chest CT or other body imaging may have been done to look for spread. Sometimes a prior biopsy report or a PET study sits alongside these.

The exact mix varies with the health system that investigated the patient. Rather than assume a standard set, list what you have and let the reviewing team say what is missing or unclear.

Two practical points matter more than the label on the scan. First, send the original DICOM image files, not only photographs of a printed film or a PDF report. Second, send the radiologist's written report for each study, because the measurements and the radiologist's interpretation are part of the record.

If a study was done at more than one hospital over time, include the earlier ones too. A series showing how a lesion changed can be as informative as a single recent scan.

Why reports alone are not enough, and images alone are not enough

A written report tells the reviewing clinician what another radiologist concluded. That is valuable, but it is a summary. The original images let the China-based team look at the lesion itself, check measurements, and judge image quality. A report without images can leave the team unable to confirm what was described.

Images without reports create a different gap. The team can see the pictures but loses the prior radiologist's measurements, comparison with earlier studies and any caveats about technique. Sending both is the practical answer.

Language is a separate issue. Reports in a language the reviewing team does not read may need translation, and the team should be asked what it requires. Do not assume a translation is mandatory or that a particular format is accepted; ask the receiving hospital what it needs and in what form.

What the treating team must confirm about new imaging in China

A common question is whether new scans will be ordered on arrival. That is a clinical decision for the treating team, and it depends on the quality and age of existing studies, the question the review is trying to answer, and the patient's condition. No article can promise that existing imaging will be accepted or that new imaging will be avoided.

Ask the hospital directly which of these applies to your case: whether your existing studies are adequate for a review, whether a repeat or additional study is likely, what preparation it needs, and how the result will be communicated. Contrast-enhanced studies involve a contrast agent, and whether that is appropriate for a particular patient is a clinical judgement, not an administrative one.

If the team proposes a new study, ask what question it is meant to answer and how the result would change the plan. That is a reasonable question for any patient facing additional imaging.

Patients should also raise any known allergy, kidney problem or other condition that could affect contrast use, so the clinical team can assess it.

Preparing the imaging file before you contact anyone

Start by gathering, for each study, the original image files on disc or through the hospital's image portal, plus the written report. Note the date and the hospital where each was done. Keep a simple list so nothing is duplicated or lost.

A short cover note helps: the diagnosis as you understand it, the date of the most recent imaging, any treatment already given, and the specific question you want answered. This is a summary, not a full archive, and it is enough for a first conversation.

Do not send passport numbers, payment details or a complete medical history at the first contact. Those can follow once the route is clear and the receiving team asks for them.

If you are unsure which studies matter, send the list and the most recent reports first. The team can then say what else would help.

Where ChinaSpecialistCare fits, and the next step

ChinaSpecialistCare provides information and non-clinical coordination. An initial case review is free: our team checks the available diagnosis, records and your main question, identifies missing information and suggests a relevant next step. That is not a diagnosis, a clinical opinion or a promise of hospital acceptance.

If a records-based specialist opinion would help before travel, a proxy consultation is available as an optional service, and a multidisciplinary review can be arranged for complex cases where the scope and fee are agreed first. Neither is a prerequisite for care, and the hospital decides suitability.

A useful next step is to gather your imaging reports and a list of your studies, then share a brief summary through the enquiry form, email or WhatsApp. Our team can tell you what the reviewing hospital would need to see, and you can ask the hospital what its own imaging requirements are for your case.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. payment
  2. Related treatment reference
  3. NICE guideline NG47: Hepatocellular carcinoma surveillance and diagnosis
  4. American College of Radiology: Appropriateness Criteria for liver cancer imaging
  5. National Cancer Institute: Liver cancer treatment information

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.